INSIGHTS ON DRUG DEVELOPMENT

• Accelerating Method Development And Manufacturing Of GLP-1 Analogs

  Explore a streamlined LC-UV/MS workflow that empowers labs to meet rising GLP-1 drug demand with faster, more informed decisions that enhance compliance and impurity detection efficiency.

• Ultra-Low Cross-Linked Microgel Purification

  ULC microgel purification is often slowed by linear polymer contamination and limitations of centrifugation. Explore how hollow fiber TFF improves filtration efficiency and supports scalable processing.

• Comprehensive Workflow For The Quantification Of Peptides And Proteins

  Biologics are transforming medicine, with semaglutide leading the way. Discover how an automated LC-MS/MS workflow enables high-sensitivity quantification of peptides in plasma.

• A Human-Relevant Model Of The Liver Sinusoid

  This organ-on-a-chip model minimizes drug absorption while maintaining the essential architecture. Explore the specifications of this product engineered to model the human liver.

• Strategic Early Material Generation For Accelerated Process Development

  5/14/2026

  Learn how early material generation strategies can accelerate biologics development, streamline process optimization, and enable scalable, production-relevant material supply from the earliest stages of development.

• Asymchem's World-Class TIDES Hub: Scaling Innovations For The Future

  3/11/2026

  A tech‑driven, integrated ecosystem strengthens TIDES development and scale‑up, enabling reliable progression from early molecular design to commercial delivery as pipelines grow more complex.

• Are You Keeping Pace With Oligo Synthesis Optimization?

  11/18/2025

  The rapidly expanding oligo market demands optimized RNA synthesis. Examine key innovations and workflow insights to maximize resources and control long-term manufacturing costs.

• Biologic Stability: A Thermofluor Screen For Rational Buffer Optimization

  9/23/2025

  Learn how thermal shift fluorimetry (thermofluor) can be used as a rapid, low-volume, and cost-effective technique to accelerate buffer optimization and enhance protein stability.

• The Art And Science Of Topical Formulations

  7/3/2025

  Chief Scientific Officer Jon Lenn discusses the balance of art and science in topical formulation development, emphasizing advanced skin models for optimized delivery, activity, and product stability.